Total Payments
$1,911
2024 Payments
$83.22
Companies
19
Transactions
87
Medicare Patients
6,700
Medicare Billing
$740,615
Payment Breakdown by Category
Food & Beverage$1,905 (99.7%)
Education$6.02 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,905 | 86 | 99.7% |
| Education | $6.02 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $250.08 | 10 | $0 (2021) |
| GlaxoSmithKline, LLC. | $249.25 | 11 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $232.06 | 9 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $229.70 | 5 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $224.71 | 10 | $0 (2021) |
| Exact Sciences Corporation | $197.47 | 4 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $152.39 | 11 | $0 (2021) |
| PFIZER INC. | $69.48 | 5 | $0 (2022) |
| Lilly USA, LLC | $61.45 | 4 | $0 (2023) |
| Novo Nordisk Inc | $54.18 | 4 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $83.22 | 5 | GlaxoSmithKline, LLC. ($29.48) |
| 2023 | $292.87 | 10 | Exact Sciences Corporation ($197.47) |
| 2022 | $101.10 | 7 | Lilly USA, LLC ($30.13) |
| 2021 | $480.03 | 19 | AstraZeneca Pharmaceuticals LP ($169.45) |
| 2020 | $162.69 | 10 | Janssen Pharmaceuticals, Inc ($63.68) |
| 2019 | $95.35 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($95.35) |
| 2018 | $262.76 | 21 | Merck Sharp & Dohme Corporation ($64.58) |
| 2017 | $433.11 | 14 | Novartis Pharmaceuticals Corporation ($211.99) |
All Payment Transactions
87 individual payment records from CMS Open Payments — Page 2 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/13/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: DIABETES | ||||||
| 09/02/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $104.52 | General |
| Category: Respiratory | ||||||
| 08/30/2021 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Neuroscience | ||||||
| 08/23/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: RESPIRATORY | ||||||
| 08/16/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/11/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: NEUROSCIENCE | ||||||
| 08/09/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: RESPIRATORY | ||||||
| 05/19/2021 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 05/13/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $108.21 | General |
| Category: RESPIRATORY | ||||||
| 05/03/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.16 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/27/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: RESPIRATORY | ||||||
| 04/14/2021 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug), JANUVIA, VERQUVO | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: NEUROSCIENCE | ||||||
| 04/05/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: RESPIRATORY | ||||||
| 03/08/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/03/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/14/2021 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug), JANUVIA, STEGLUJAN | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Diabetes | ||||||
| 11/16/2020 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 11/11/2020 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: RESPIRATORY | ||||||
| 11/10/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, STEGLATRO | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/26/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/03/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/30/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, STEGLATRO | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/03/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $34.87 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/27/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, STEGLATRO | Food and Beverage | In-kind items and services | $12.82 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,440 | 3,687 | $455,583 | $160,748 |
| 2022 | 18 | 1,492 | 3,858 | $478,931 | $179,869 |
| 2021 | 21 | 1,782 | 4,571 | $517,660 | $204,146 |
| 2020 | 16 | 1,986 | 5,195 | $534,255 | $195,852 |
Total Patients
6,700
Total Services
17,311
Medicare Billing
$740,615
Procedure Codes
71
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 2 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 12 | 13 | $1,300 | $480.13 | 36.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 60 | 490 | $5,880 | $405.77 | 6.9% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 12 | 12 | $432.00 | $252.52 | 58.5% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2022 | 18 | 19 | $456.00 | $163.91 | 35.9% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 23 | 24 | $432.00 | $156.13 | 36.1% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 13 | 13 | $338.00 | $92.80 | 27.5% |
| 81003 | Automated urinalysis test | Office | 2022 | 28 | 39 | $468.00 | $86.56 | 18.5% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2022 | 11 | 12 | $204.00 | $76.76 | 37.6% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 60 | 490 | $4,900 | $42.83 | 0.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 294 | 1,558 | $353,666 | $132,973 | 37.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 234 | 234 | $48,204 | $29,663 | 61.5% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 152 | 152 | $15,960 | $9,965 | 62.4% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 52 | 52 | $20,384 | $8,291 | 40.7% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 20 | 22 | $6,688 | $3,474 | 51.9% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 456 | 612 | $22,032 | $3,474 | 15.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 163 | 163 | $4,401 | $2,564 | 58.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 24 | 24 | $7,488 | $2,470 | 33.0% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 71 | 235 | $10,810 | $2,375 | 22.0% |
| 90670 | Pneumococcal vaccine for injection into muscle | Office | 2021 | 11 | 11 | $3,509 | $2,369 | 67.5% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 17 | 17 | $2,788 | $2,111 | 75.7% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2021 | 12 | 12 | $2,681 | $1,948 | 72.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 73 | 672 | $8,064 | $613.76 | 7.6% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 13 | 15 | $1,500 | $605.40 | 40.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 25 | 25 | $675.00 | $393.65 | 58.3% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent, preservation free | Office | 2021 | 13 | 13 | $468.00 | $266.89 | 57.0% |
About Dr. Romeo Obsequio, MD
Dr. Romeo Obsequio, MD is a Internal Medicine healthcare provider based in Miami, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508839093.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Romeo Obsequio, MD has received a total of $1,911 in payments from pharmaceutical and medical device companies, with $83.22 received in 2024. These payments were reported across 87 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,905).
As a Medicare-enrolled provider, Obsequio has provided services to 6,700 Medicare beneficiaries, totaling 17,311 services with total Medicare billing of $740,615. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Miami, OK
- Active Since 02/07/2006
- Last Updated 01/27/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1508839093
Products in Payments
- XARELTO (Drug) $244.06
- JARDIANCE (Drug) $229.84
- ENTRESTO (Drug) $224.71
- TRELEGY ELLIPTA (Drug) $210.38
- Cologuard Collection Kit (Device) $197.47
- FARXIGA (Drug) $127.54
- JANUVIA (Drug) $105.90
- BREZTRI (Drug) $104.52
- CHANTIX (Drug) $44.22
- BELSOMRA (Drug) $31.69
- STIOLTO RESPIMAT (Drug) $31.18
- UTIBRON (Drug) $29.91
- PREVNAR 13 (Biological) $25.26
- UBRELVY (Drug) $23.17
- REXULTI (Drug) $22.98
- Utibron (Drug) $19.89
- TRULICITY (Drug) $17.63
- TOUJEO (Drug) $17.39
- Ozempic (Drug) $16.77
- NEXLETOL (Drug) $16.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Miami
Jay Skyler, Md, MD
Internal Medicine — Payments: $2.9M
Internal Medicine $2.9M
Dr. Lukasz Kwapisz
Internal Medicine — Payments: $800,664
Internal Medicine $800,664
Mark Kutner, Md, MD
Internal Medicine — Payments: $610,516
Internal Medicine $610,516
Dr. Ian Del Conde Pozzi, M.d, M.D
Internal Medicine — Payments: $499,756
Internal Medicine $499,756
Mr. Angel Carrasco, M.d, M.D
Internal Medicine — Payments: $493,362
Internal Medicine $493,362
Dr. Edward Mezerhane, Md, MD
Internal Medicine — Payments: $470,504
Internal Medicine $470,504